nodes	percent_of_prediction	percent_of_DWPC	metapath
Thiotepa—CYP2B6—Dexamethasone—psoriatic arthritis	0.14	0.234	CbGbCtD
Thiotepa—CYP3A4—Methylprednisolone—psoriatic arthritis	0.114	0.19	CbGbCtD
Thiotepa—CYP3A4—Triamcinolone—psoriatic arthritis	0.0864	0.144	CbGbCtD
Thiotepa—CYP3A4—Betamethasone—psoriatic arthritis	0.0741	0.124	CbGbCtD
Thiotepa—CYP3A4—Prednisolone—psoriatic arthritis	0.0731	0.122	CbGbCtD
Thiotepa—CYP3A4—Prednisone—psoriatic arthritis	0.0691	0.115	CbGbCtD
Thiotepa—CYP3A4—Dexamethasone—psoriatic arthritis	0.0431	0.0718	CbGbCtD
Thiotepa—Erythema—Methylprednisolone—psoriatic arthritis	0.000621	0.00155	CcSEcCtD
Thiotepa—Malnutrition—Methylprednisolone—psoriatic arthritis	0.000621	0.00155	CcSEcCtD
Thiotepa—Eye disorder—Betamethasone—psoriatic arthritis	0.000607	0.00152	CcSEcCtD
Thiotepa—Eye disorder—Dexamethasone—psoriatic arthritis	0.000607	0.00152	CcSEcCtD
Thiotepa—Back pain—Triamcinolone—psoriatic arthritis	0.000602	0.00151	CcSEcCtD
Thiotepa—Angiopathy—Betamethasone—psoriatic arthritis	0.000589	0.00147	CcSEcCtD
Thiotepa—Angiopathy—Dexamethasone—psoriatic arthritis	0.000589	0.00147	CcSEcCtD
Thiotepa—Convulsion—Prednisolone—psoriatic arthritis	0.000587	0.00147	CcSEcCtD
Thiotepa—Hypertension—Prednisolone—psoriatic arthritis	0.000585	0.00146	CcSEcCtD
Thiotepa—Arrhythmia—Betamethasone—psoriatic arthritis	0.00058	0.00145	CcSEcCtD
Thiotepa—Arrhythmia—Dexamethasone—psoriatic arthritis	0.00058	0.00145	CcSEcCtD
Thiotepa—Alopecia—Dexamethasone—psoriatic arthritis	0.000574	0.00143	CcSEcCtD
Thiotepa—Alopecia—Betamethasone—psoriatic arthritis	0.000574	0.00143	CcSEcCtD
Thiotepa—Haemoglobin—Prednisone—psoriatic arthritis	0.000568	0.00142	CcSEcCtD
Thiotepa—Haemorrhage—Prednisone—psoriatic arthritis	0.000565	0.00141	CcSEcCtD
Thiotepa—Erythema—Dexamethasone—psoriatic arthritis	0.000565	0.00141	CcSEcCtD
Thiotepa—Erythema—Betamethasone—psoriatic arthritis	0.000565	0.00141	CcSEcCtD
Thiotepa—Hallucination—Prednisone—psoriatic arthritis	0.000563	0.00141	CcSEcCtD
Thiotepa—Pancytopenia—Methotrexate—psoriatic arthritis	0.000561	0.0014	CcSEcCtD
Thiotepa—Connective tissue disorder—Prednisone—psoriatic arthritis	0.000556	0.00139	CcSEcCtD
Thiotepa—Dysuria—Methotrexate—psoriatic arthritis	0.000552	0.00138	CcSEcCtD
Thiotepa—Cough—Triamcinolone—psoriatic arthritis	0.000543	0.00136	CcSEcCtD
Thiotepa—Convulsion—Triamcinolone—psoriatic arthritis	0.00054	0.00135	CcSEcCtD
Thiotepa—Tachycardia—Prednisolone—psoriatic arthritis	0.000539	0.00135	CcSEcCtD
Thiotepa—Convulsion—Methylprednisolone—psoriatic arthritis	0.000538	0.00135	CcSEcCtD
Thiotepa—Hypertension—Triamcinolone—psoriatic arthritis	0.000538	0.00134	CcSEcCtD
Thiotepa—Hypertension—Methylprednisolone—psoriatic arthritis	0.000537	0.00134	CcSEcCtD
Thiotepa—Myalgia—Triamcinolone—psoriatic arthritis	0.00053	0.00133	CcSEcCtD
Thiotepa—Pneumonia—Methotrexate—psoriatic arthritis	0.000529	0.00132	CcSEcCtD
Thiotepa—Arthralgia—Methylprednisolone—psoriatic arthritis	0.000529	0.00132	CcSEcCtD
Thiotepa—Myalgia—Methylprednisolone—psoriatic arthritis	0.000529	0.00132	CcSEcCtD
Thiotepa—Eye disorder—Prednisone—psoriatic arthritis	0.000528	0.00132	CcSEcCtD
Thiotepa—Anxiety—Methylprednisolone—psoriatic arthritis	0.000527	0.00132	CcSEcCtD
Thiotepa—Infestation NOS—Methotrexate—psoriatic arthritis	0.000526	0.00132	CcSEcCtD
Thiotepa—Infestation—Methotrexate—psoriatic arthritis	0.000526	0.00132	CcSEcCtD
Thiotepa—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.000525	0.00131	CcSEcCtD
Thiotepa—Renal failure—Methotrexate—psoriatic arthritis	0.000517	0.00129	CcSEcCtD
Thiotepa—Stomatitis—Methotrexate—psoriatic arthritis	0.000513	0.00128	CcSEcCtD
Thiotepa—Angiopathy—Prednisone—psoriatic arthritis	0.000513	0.00128	CcSEcCtD
Thiotepa—Conjunctivitis—Methotrexate—psoriatic arthritis	0.000512	0.00128	CcSEcCtD
Thiotepa—Confusional state—Methylprednisolone—psoriatic arthritis	0.000511	0.00128	CcSEcCtD
Thiotepa—Immune system disorder—Prednisone—psoriatic arthritis	0.000511	0.00128	CcSEcCtD
Thiotepa—Arrhythmia—Prednisone—psoriatic arthritis	0.000505	0.00126	CcSEcCtD
Thiotepa—Infection—Triamcinolone—psoriatic arthritis	0.000505	0.00126	CcSEcCtD
Thiotepa—Infection—Methylprednisolone—psoriatic arthritis	0.000504	0.00126	CcSEcCtD
Thiotepa—Haematuria—Methotrexate—psoriatic arthritis	0.000502	0.00126	CcSEcCtD
Thiotepa—Alopecia—Prednisone—psoriatic arthritis	0.0005	0.00125	CcSEcCtD
Thiotepa—Hepatobiliary disease—Methotrexate—psoriatic arthritis	0.000498	0.00125	CcSEcCtD
Thiotepa—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.000497	0.00124	CcSEcCtD
Thiotepa—Epistaxis—Methotrexate—psoriatic arthritis	0.000496	0.00124	CcSEcCtD
Thiotepa—Paraesthesia—Prednisolone—psoriatic arthritis	0.000496	0.00124	CcSEcCtD
Thiotepa—Tachycardia—Triamcinolone—psoriatic arthritis	0.000496	0.00124	CcSEcCtD
Thiotepa—Mental disorder—Prednisone—psoriatic arthritis	0.000495	0.00124	CcSEcCtD
Thiotepa—Tachycardia—Methylprednisolone—psoriatic arthritis	0.000495	0.00124	CcSEcCtD
Thiotepa—Skin disorder—Methylprednisolone—psoriatic arthritis	0.000493	0.00123	CcSEcCtD
Thiotepa—Erythema—Prednisone—psoriatic arthritis	0.000492	0.00123	CcSEcCtD
Thiotepa—Malnutrition—Prednisone—psoriatic arthritis	0.000492	0.00123	CcSEcCtD
Thiotepa—Agranulocytosis—Methotrexate—psoriatic arthritis	0.000491	0.00123	CcSEcCtD
Thiotepa—Convulsion—Dexamethasone—psoriatic arthritis	0.00049	0.00122	CcSEcCtD
Thiotepa—Convulsion—Betamethasone—psoriatic arthritis	0.00049	0.00122	CcSEcCtD
Thiotepa—Hypertension—Betamethasone—psoriatic arthritis	0.000488	0.00122	CcSEcCtD
Thiotepa—Hypertension—Dexamethasone—psoriatic arthritis	0.000488	0.00122	CcSEcCtD
Thiotepa—Myalgia—Betamethasone—psoriatic arthritis	0.000481	0.0012	CcSEcCtD
Thiotepa—Myalgia—Dexamethasone—psoriatic arthritis	0.000481	0.0012	CcSEcCtD
Thiotepa—Anxiety—Dexamethasone—psoriatic arthritis	0.000479	0.0012	CcSEcCtD
Thiotepa—Anxiety—Betamethasone—psoriatic arthritis	0.000479	0.0012	CcSEcCtD
Thiotepa—Haemoglobin—Methotrexate—psoriatic arthritis	0.000475	0.00119	CcSEcCtD
Thiotepa—Pain—Prednisolone—psoriatic arthritis	0.000473	0.00118	CcSEcCtD
Thiotepa—Haemorrhage—Methotrexate—psoriatic arthritis	0.000472	0.00118	CcSEcCtD
Thiotepa—Urinary tract disorder—Methotrexate—psoriatic arthritis	0.000467	0.00117	CcSEcCtD
Thiotepa—Vision blurred—Prednisone—psoriatic arthritis	0.000464	0.00116	CcSEcCtD
Thiotepa—Urethral disorder—Methotrexate—psoriatic arthritis	0.000463	0.00116	CcSEcCtD
Thiotepa—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.000463	0.00116	CcSEcCtD
Thiotepa—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.000462	0.00116	CcSEcCtD
Thiotepa—Infection—Betamethasone—psoriatic arthritis	0.000458	0.00115	CcSEcCtD
Thiotepa—Infection—Dexamethasone—psoriatic arthritis	0.000458	0.00115	CcSEcCtD
Thiotepa—Paraesthesia—Triamcinolone—psoriatic arthritis	0.000456	0.00114	CcSEcCtD
Thiotepa—Feeling abnormal—Prednisolone—psoriatic arthritis	0.000455	0.00114	CcSEcCtD
Thiotepa—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.000455	0.00114	CcSEcCtD
Thiotepa—Anaemia—Prednisone—psoriatic arthritis	0.000455	0.00114	CcSEcCtD
Thiotepa—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.000452	0.00113	CcSEcCtD
Thiotepa—Nervous system disorder—Betamethasone—psoriatic arthritis	0.000452	0.00113	CcSEcCtD
Thiotepa—Agitation—Prednisone—psoriatic arthritis	0.000452	0.00113	CcSEcCtD
Thiotepa—Thrombocytopenia—Betamethasone—psoriatic arthritis	0.000452	0.00113	CcSEcCtD
Thiotepa—Thrombocytopenia—Dexamethasone—psoriatic arthritis	0.000452	0.00113	CcSEcCtD
Thiotepa—Tachycardia—Betamethasone—psoriatic arthritis	0.00045	0.00113	CcSEcCtD
Thiotepa—Tachycardia—Dexamethasone—psoriatic arthritis	0.00045	0.00113	CcSEcCtD
Thiotepa—Dyspepsia—Triamcinolone—psoriatic arthritis	0.000447	0.00112	CcSEcCtD
Thiotepa—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.000446	0.00112	CcSEcCtD
Thiotepa—Eye disorder—Methotrexate—psoriatic arthritis	0.000442	0.0011	CcSEcCtD
Thiotepa—Tinnitus—Methotrexate—psoriatic arthritis	0.000441	0.0011	CcSEcCtD
Thiotepa—Anorexia—Betamethasone—psoriatic arthritis	0.00044	0.0011	CcSEcCtD
Thiotepa—Anorexia—Dexamethasone—psoriatic arthritis	0.00044	0.0011	CcSEcCtD
Thiotepa—Urticaria—Prednisolone—psoriatic arthritis	0.000439	0.0011	CcSEcCtD
Thiotepa—Cardiac disorder—Methotrexate—psoriatic arthritis	0.000439	0.0011	CcSEcCtD
Thiotepa—Fatigue—Triamcinolone—psoriatic arthritis	0.000438	0.0011	CcSEcCtD
Thiotepa—Fatigue—Methylprednisolone—psoriatic arthritis	0.000437	0.00109	CcSEcCtD
Thiotepa—Pain—Triamcinolone—psoriatic arthritis	0.000435	0.00109	CcSEcCtD
Thiotepa—Angiopathy—Methotrexate—psoriatic arthritis	0.000429	0.00107	CcSEcCtD
Thiotepa—Immune system disorder—Methotrexate—psoriatic arthritis	0.000427	0.00107	CcSEcCtD
Thiotepa—Convulsion—Prednisone—psoriatic arthritis	0.000426	0.00107	CcSEcCtD
Thiotepa—Mediastinal disorder—Methotrexate—psoriatic arthritis	0.000426	0.00107	CcSEcCtD
Thiotepa—Hypertension—Prednisone—psoriatic arthritis	0.000425	0.00106	CcSEcCtD
Thiotepa—Chills—Methotrexate—psoriatic arthritis	0.000424	0.00106	CcSEcCtD
Thiotepa—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.00042	0.00105	CcSEcCtD
Thiotepa—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.00042	0.00105	CcSEcCtD
Thiotepa—Myalgia—Prednisone—psoriatic arthritis	0.000419	0.00105	CcSEcCtD
Thiotepa—Arthralgia—Prednisone—psoriatic arthritis	0.000419	0.00105	CcSEcCtD
Thiotepa—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.000419	0.00105	CcSEcCtD
Thiotepa—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.000418	0.00105	CcSEcCtD
Thiotepa—Anxiety—Prednisone—psoriatic arthritis	0.000418	0.00104	CcSEcCtD
Thiotepa—Alopecia—Methotrexate—psoriatic arthritis	0.000418	0.00104	CcSEcCtD
Thiotepa—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.000416	0.00104	CcSEcCtD
Thiotepa—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.000415	0.00104	CcSEcCtD
Thiotepa—Paraesthesia—Dexamethasone—psoriatic arthritis	0.000414	0.00104	CcSEcCtD
Thiotepa—Paraesthesia—Betamethasone—psoriatic arthritis	0.000414	0.00104	CcSEcCtD
Thiotepa—Mental disorder—Methotrexate—psoriatic arthritis	0.000414	0.00104	CcSEcCtD
Thiotepa—Malnutrition—Methotrexate—psoriatic arthritis	0.000411	0.00103	CcSEcCtD
Thiotepa—Erythema—Methotrexate—psoriatic arthritis	0.000411	0.00103	CcSEcCtD
Thiotepa—Hypersensitivity—Prednisolone—psoriatic arthritis	0.000407	0.00102	CcSEcCtD
Thiotepa—Dyspepsia—Dexamethasone—psoriatic arthritis	0.000406	0.00102	CcSEcCtD
Thiotepa—Dyspepsia—Betamethasone—psoriatic arthritis	0.000406	0.00102	CcSEcCtD
Thiotepa—Urticaria—Triamcinolone—psoriatic arthritis	0.000404	0.00101	CcSEcCtD
Thiotepa—Urticaria—Methylprednisolone—psoriatic arthritis	0.000403	0.00101	CcSEcCtD
Thiotepa—Body temperature increased—Triamcinolone—psoriatic arthritis	0.000402	0.00101	CcSEcCtD
Thiotepa—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.000401	0.001	CcSEcCtD
Thiotepa—Decreased appetite—Dexamethasone—psoriatic arthritis	0.000401	0.001	CcSEcCtD
Thiotepa—Decreased appetite—Betamethasone—psoriatic arthritis	0.000401	0.001	CcSEcCtD
Thiotepa—Infection—Prednisone—psoriatic arthritis	0.000399	0.000998	CcSEcCtD
Thiotepa—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.000398	0.000996	CcSEcCtD
Thiotepa—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.000398	0.000996	CcSEcCtD
Thiotepa—Back pain—Methotrexate—psoriatic arthritis	0.000398	0.000995	CcSEcCtD
Thiotepa—Fatigue—Dexamethasone—psoriatic arthritis	0.000398	0.000995	CcSEcCtD
Thiotepa—Fatigue—Betamethasone—psoriatic arthritis	0.000398	0.000995	CcSEcCtD
Thiotepa—Pain—Dexamethasone—psoriatic arthritis	0.000394	0.000986	CcSEcCtD
Thiotepa—Pain—Betamethasone—psoriatic arthritis	0.000394	0.000986	CcSEcCtD
Thiotepa—Nervous system disorder—Prednisone—psoriatic arthritis	0.000394	0.000985	CcSEcCtD
Thiotepa—Tachycardia—Prednisone—psoriatic arthritis	0.000392	0.00098	CcSEcCtD
Thiotepa—Skin disorder—Prednisone—psoriatic arthritis	0.00039	0.000976	CcSEcCtD
Thiotepa—Vision blurred—Methotrexate—psoriatic arthritis	0.000388	0.00097	CcSEcCtD
Thiotepa—Anorexia—Prednisone—psoriatic arthritis	0.000383	0.000958	CcSEcCtD
Thiotepa—Anaemia—Methotrexate—psoriatic arthritis	0.00038	0.000951	CcSEcCtD
Thiotepa—Feeling abnormal—Betamethasone—psoriatic arthritis	0.00038	0.000951	CcSEcCtD
Thiotepa—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.00038	0.000951	CcSEcCtD
Thiotepa—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.000377	0.000943	CcSEcCtD
Thiotepa—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.000377	0.000943	CcSEcCtD
Thiotepa—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.000375	0.000937	CcSEcCtD
Thiotepa—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.000374	0.000935	CcSEcCtD
Thiotepa—Leukopenia—Methotrexate—psoriatic arthritis	0.000368	0.000921	CcSEcCtD
Thiotepa—Urticaria—Dexamethasone—psoriatic arthritis	0.000366	0.000916	CcSEcCtD
Thiotepa—Urticaria—Betamethasone—psoriatic arthritis	0.000366	0.000916	CcSEcCtD
Thiotepa—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.000366	0.000915	CcSEcCtD
Thiotepa—Dizziness—Prednisolone—psoriatic arthritis	0.000366	0.000914	CcSEcCtD
Thiotepa—Asthenia—Triamcinolone—psoriatic arthritis	0.000365	0.000912	CcSEcCtD
Thiotepa—Abdominal pain—Dexamethasone—psoriatic arthritis	0.000365	0.000912	CcSEcCtD
Thiotepa—Body temperature increased—Dexamethasone—psoriatic arthritis	0.000365	0.000912	CcSEcCtD
Thiotepa—Abdominal pain—Betamethasone—psoriatic arthritis	0.000365	0.000912	CcSEcCtD
Thiotepa—Body temperature increased—Betamethasone—psoriatic arthritis	0.000365	0.000912	CcSEcCtD
Thiotepa—Asthenia—Methylprednisolone—psoriatic arthritis	0.000364	0.00091	CcSEcCtD
Thiotepa—Paraesthesia—Prednisone—psoriatic arthritis	0.000361	0.000902	CcSEcCtD
Thiotepa—Pruritus—Triamcinolone—psoriatic arthritis	0.00036	0.000899	CcSEcCtD
Thiotepa—Cough—Methotrexate—psoriatic arthritis	0.000359	0.000898	CcSEcCtD
Thiotepa—Pruritus—Methylprednisolone—psoriatic arthritis	0.000359	0.000897	CcSEcCtD
Thiotepa—Convulsion—Methotrexate—psoriatic arthritis	0.000356	0.000891	CcSEcCtD
Thiotepa—Dyspepsia—Prednisone—psoriatic arthritis	0.000354	0.000884	CcSEcCtD
Thiotepa—Arthralgia—Methotrexate—psoriatic arthritis	0.00035	0.000876	CcSEcCtD
Thiotepa—Myalgia—Methotrexate—psoriatic arthritis	0.00035	0.000876	CcSEcCtD
Thiotepa—Decreased appetite—Prednisone—psoriatic arthritis	0.000349	0.000873	CcSEcCtD
Thiotepa—Rash—Prednisolone—psoriatic arthritis	0.000349	0.000872	CcSEcCtD
Thiotepa—Dermatitis—Prednisolone—psoriatic arthritis	0.000348	0.000871	CcSEcCtD
Thiotepa—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.000348	0.00087	CcSEcCtD
Thiotepa—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.000347	0.000868	CcSEcCtD
Thiotepa—Fatigue—Prednisone—psoriatic arthritis	0.000346	0.000866	CcSEcCtD
Thiotepa—Headache—Prednisolone—psoriatic arthritis	0.000346	0.000866	CcSEcCtD
Thiotepa—Constipation—Prednisone—psoriatic arthritis	0.000343	0.000859	CcSEcCtD
Thiotepa—Confusional state—Methotrexate—psoriatic arthritis	0.000338	0.000847	CcSEcCtD
Thiotepa—Dizziness—Triamcinolone—psoriatic arthritis	0.000336	0.000841	CcSEcCtD
Thiotepa—Dizziness—Methylprednisolone—psoriatic arthritis	0.000335	0.000839	CcSEcCtD
Thiotepa—Infection—Methotrexate—psoriatic arthritis	0.000333	0.000834	CcSEcCtD
Thiotepa—Feeling abnormal—Prednisone—psoriatic arthritis	0.000331	0.000828	CcSEcCtD
Thiotepa—Asthenia—Betamethasone—psoriatic arthritis	0.000331	0.000828	CcSEcCtD
Thiotepa—Asthenia—Dexamethasone—psoriatic arthritis	0.000331	0.000828	CcSEcCtD
Thiotepa—Nervous system disorder—Methotrexate—psoriatic arthritis	0.000329	0.000823	CcSEcCtD
Thiotepa—Thrombocytopenia—Methotrexate—psoriatic arthritis	0.000329	0.000822	CcSEcCtD
Thiotepa—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.000328	0.000822	CcSEcCtD
Thiotepa—Nausea—Prednisolone—psoriatic arthritis	0.000328	0.000821	CcSEcCtD
Thiotepa—Pruritus—Betamethasone—psoriatic arthritis	0.000326	0.000816	CcSEcCtD
Thiotepa—Pruritus—Dexamethasone—psoriatic arthritis	0.000326	0.000816	CcSEcCtD
Thiotepa—Skin disorder—Methotrexate—psoriatic arthritis	0.000326	0.000816	CcSEcCtD
Thiotepa—Vomiting—Triamcinolone—psoriatic arthritis	0.000323	0.000808	CcSEcCtD
Thiotepa—Vomiting—Methylprednisolone—psoriatic arthritis	0.000322	0.000807	CcSEcCtD
Thiotepa—Rash—Triamcinolone—psoriatic arthritis	0.00032	0.000802	CcSEcCtD
Thiotepa—Dermatitis—Triamcinolone—psoriatic arthritis	0.00032	0.000801	CcSEcCtD
Thiotepa—Anorexia—Methotrexate—psoriatic arthritis	0.00032	0.0008	CcSEcCtD
Thiotepa—Rash—Methylprednisolone—psoriatic arthritis	0.00032	0.0008	CcSEcCtD
Thiotepa—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000319	0.000799	CcSEcCtD
Thiotepa—Urticaria—Prednisone—psoriatic arthritis	0.000319	0.000798	CcSEcCtD
Thiotepa—Headache—Triamcinolone—psoriatic arthritis	0.000318	0.000796	CcSEcCtD
Thiotepa—Headache—Methylprednisolone—psoriatic arthritis	0.000318	0.000795	CcSEcCtD
Thiotepa—Body temperature increased—Prednisone—psoriatic arthritis	0.000318	0.000794	CcSEcCtD
Thiotepa—Abdominal pain—Prednisone—psoriatic arthritis	0.000318	0.000794	CcSEcCtD
Thiotepa—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000316	0.000789	CcSEcCtD
Thiotepa—Diarrhoea—Betamethasone—psoriatic arthritis	0.000316	0.000789	CcSEcCtD
Thiotepa—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.000306	0.000765	CcSEcCtD
Thiotepa—Dizziness—Betamethasone—psoriatic arthritis	0.000305	0.000763	CcSEcCtD
Thiotepa—Dizziness—Dexamethasone—psoriatic arthritis	0.000305	0.000763	CcSEcCtD
Thiotepa—Nausea—Triamcinolone—psoriatic arthritis	0.000302	0.000755	CcSEcCtD
Thiotepa—Paraesthesia—Methotrexate—psoriatic arthritis	0.000301	0.000754	CcSEcCtD
Thiotepa—Nausea—Methylprednisolone—psoriatic arthritis	0.000301	0.000754	CcSEcCtD
Thiotepa—Somnolence—Methotrexate—psoriatic arthritis	0.000298	0.000746	CcSEcCtD
Thiotepa—Hypersensitivity—Prednisone—psoriatic arthritis	0.000296	0.00074	CcSEcCtD
Thiotepa—Dyspepsia—Methotrexate—psoriatic arthritis	0.000295	0.000739	CcSEcCtD
Thiotepa—Vomiting—Betamethasone—psoriatic arthritis	0.000293	0.000733	CcSEcCtD
Thiotepa—Vomiting—Dexamethasone—psoriatic arthritis	0.000293	0.000733	CcSEcCtD
Thiotepa—Decreased appetite—Methotrexate—psoriatic arthritis	0.000292	0.00073	CcSEcCtD
Thiotepa—Rash—Dexamethasone—psoriatic arthritis	0.000291	0.000727	CcSEcCtD
Thiotepa—Rash—Betamethasone—psoriatic arthritis	0.000291	0.000727	CcSEcCtD
Thiotepa—Dermatitis—Dexamethasone—psoriatic arthritis	0.000291	0.000727	CcSEcCtD
Thiotepa—Dermatitis—Betamethasone—psoriatic arthritis	0.000291	0.000727	CcSEcCtD
Thiotepa—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.00029	0.000725	CcSEcCtD
Thiotepa—Fatigue—Methotrexate—psoriatic arthritis	0.000289	0.000724	CcSEcCtD
Thiotepa—Headache—Dexamethasone—psoriatic arthritis	0.000289	0.000723	CcSEcCtD
Thiotepa—Headache—Betamethasone—psoriatic arthritis	0.000289	0.000723	CcSEcCtD
Thiotepa—Asthenia—Prednisone—psoriatic arthritis	0.000288	0.000721	CcSEcCtD
Thiotepa—Pain—Methotrexate—psoriatic arthritis	0.000287	0.000718	CcSEcCtD
Thiotepa—Pruritus—Prednisone—psoriatic arthritis	0.000284	0.000711	CcSEcCtD
Thiotepa—Feeling abnormal—Methotrexate—psoriatic arthritis	0.000277	0.000692	CcSEcCtD
Thiotepa—Diarrhoea—Prednisone—psoriatic arthritis	0.000275	0.000687	CcSEcCtD
Thiotepa—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.000274	0.000687	CcSEcCtD
Thiotepa—Nausea—Dexamethasone—psoriatic arthritis	0.000274	0.000685	CcSEcCtD
Thiotepa—Nausea—Betamethasone—psoriatic arthritis	0.000274	0.000685	CcSEcCtD
Thiotepa—Urticaria—Methotrexate—psoriatic arthritis	0.000267	0.000667	CcSEcCtD
Thiotepa—Dizziness—Prednisone—psoriatic arthritis	0.000266	0.000664	CcSEcCtD
Thiotepa—Abdominal pain—Methotrexate—psoriatic arthritis	0.000265	0.000664	CcSEcCtD
Thiotepa—Body temperature increased—Methotrexate—psoriatic arthritis	0.000265	0.000664	CcSEcCtD
Thiotepa—Vomiting—Prednisone—psoriatic arthritis	0.000255	0.000639	CcSEcCtD
Thiotepa—Rash—Prednisone—psoriatic arthritis	0.000253	0.000633	CcSEcCtD
Thiotepa—Dermatitis—Prednisone—psoriatic arthritis	0.000253	0.000633	CcSEcCtD
Thiotepa—Headache—Prednisone—psoriatic arthritis	0.000252	0.000629	CcSEcCtD
Thiotepa—Hypersensitivity—Methotrexate—psoriatic arthritis	0.000247	0.000619	CcSEcCtD
Thiotepa—Asthenia—Methotrexate—psoriatic arthritis	0.000241	0.000602	CcSEcCtD
Thiotepa—Nausea—Prednisone—psoriatic arthritis	0.000239	0.000597	CcSEcCtD
Thiotepa—Pruritus—Methotrexate—psoriatic arthritis	0.000237	0.000594	CcSEcCtD
Thiotepa—Diarrhoea—Methotrexate—psoriatic arthritis	0.00023	0.000574	CcSEcCtD
Thiotepa—Dizziness—Methotrexate—psoriatic arthritis	0.000222	0.000555	CcSEcCtD
Thiotepa—Vomiting—Methotrexate—psoriatic arthritis	0.000213	0.000534	CcSEcCtD
Thiotepa—Rash—Methotrexate—psoriatic arthritis	0.000212	0.000529	CcSEcCtD
Thiotepa—Dermatitis—Methotrexate—psoriatic arthritis	0.000211	0.000529	CcSEcCtD
Thiotepa—Headache—Methotrexate—psoriatic arthritis	0.00021	0.000526	CcSEcCtD
Thiotepa—Nausea—Methotrexate—psoriatic arthritis	0.000199	0.000499	CcSEcCtD
